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Abstract
Many epidemiological evidences have proven the association between smoking and periodontal disease. The caus-
ality can be further established by linking findings of traditional epidemiological studies with the developments in
molecular techniques that occurred in the last decade. The present article reviews recent studies that address the
effect of smoking on molecular and genetic factors in periodontal disease. Most findings support the fact that
tobacco smoking modulates destruction of the periodontium through different pathways: microcirculatory and
host immune systems, connective tissue, and bone metabolism. Although smokers experience an increased burden
of inflammatory responses to microbial challenges compared to non-smokers, understanding the association
between smoking and periodontal diseases involves substantial problems with respect to accuracy of measure-
ments, and particularly, sampling of many subjects. It remains unclear whether genetic susceptibility to periodontal
disease is influenced by exposure to smoking or the effect of smoking on periodontal disease is influenced by
genetic susceptibility. Employment of molecular techniques may play a key role in further elucidation of mechan-
isms linking smoking and periodontal destruction, the direct relationship as environmental factors and indirect rela-
tionship through genetic factors.
Background
Periodontal disease is defined as inflammatory destruc-
tion of periodontal tissue and alveolar bone supporting
the teeth. Severe and prolonged periodontal inflamma-
tion leads to loss of teeth, thereby affecting oral func-
tions (e.g., mastication, speech, and facial esthetics).
Progression and severity of the disease depends on com-
plex interactions between several risk factors such as
microbial, immunological, environmental, and genetic
factors, as well as age, sex, and race [1]. Tobacco smok-
ing is a significant risk factor for periodontal disease [2].
Epidemiological studies concerning the association
between smoking and periodontal disease have markedly
increased since the 1990s. Based on epidemiological arti-
cles published from 1965 to 2000, the US Surgeon Gen-
eral’s Report 2004, which comprehensively addressed
active smoking and health issues, concluded that there
is sufficient evidence to infer a causal relationship
between smoking and periodontal disease [3]. Although
biological plausibility is an important criterion in the
Bradford-Hill criteria for assigning causality to an
association [4], traditional epidemiology correlates expo-
sure with disease outcomes, and everything between the
cause and outcome is treated as a “black box” [5].
Despite numerous studies having demonstrated the
causal association between smoking and periodontal dis-
ease, many questions remain unanswered. For example,
what happens when periodontal tissue is exposed to
tobacco smoke? How is the onset or progression of peri-
odontal disease in smokers different from that in non-
smokers? The underlying mechanisms of smoking-
attributed periodontal disease can be further clarified by
linking findings of traditional epidemiological studies
with those of in vitro studies. Recently, molecular, cellu-
lar, and other biological markers (called biomarkers)
have been frequently measured in epidemiological stu-
dies to reveal the mechanisms and events occurring
along the theoretical continuum between exposure to
tobacco smoke and the disease.
These biomarkers can be categorized according to the
target of qualification, i.e., host responses and genetic
factors (Table 1). Host responses can be further grouped
as the microcirculatory system, host immune inflamma-
tory response system, and connective tissue and bone
metabolism. Since the application of a sampling
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particularly in non-diseased smokers [6], saliva, blood
serum, and gingival crevicular fluid (GCF) are used as
specimens.
Biological mechanisms of periodontal diseases are
characterized by imbalance between bacterial virulence
and host defense activity. The most plausible mechan-
ism that explains the relationship between smoking and
periodontal disease is that smoking, an environmental
factor, interacts with host cells and affects inflammatory
responses to microbial challenge [7]. Alternatively, the
toxic components of tobacco smoke, e.g., nicotine, may
directly or indirectly deteriorate periodontal tissue.
Recently, genetic susceptibility to periodontal disease
has been receiving much attention with respect to
smoking-periodontal disease relationships. This review
describes smoking as an environmental factor of period-
ontal disease and the interrelationship between smoking
and genetic factors in periodontal disease in studies
using molecular biology techniques.
Search strategy
The PubMed database was examined for English lan-
guage publications from 1965 to 2008, using the follow-
ing key words: “smoking,”“ smokers,”“ tobacco,”
“periodontal diseases,” and “periodontitis.” These terms
were mainly searched as title words. Epidemiological
studies not employing biological measurements and
review articles were excluded. Most of the articles were
published in the last 10-15 years. Consequently, 134 stu-
dies were evaluated and 60 have been included in this
review.
Inflammatory host responses
Microcirculatory System
Changes in vascular formations and microcirculatory
functions in periodontal tissue following smoking can
influence immune function and the subsequent inflam-
matory reaction in the gingiva. A significantly smaller
number of vessels were observed in the inflamed gingi-
val tissues of smokers compared to non-smokers [8].
Continuous smoking has a long-term effect that impairs
the vasculature of periodontal tissue. Acute exposure to
cigarette smoke induces gingival hyperemia, which is
caused by the concomitant increase in blood pressure
against a small but significant sympathetically induced
vasoconstriction in healthy gingiva [9]. Smoking even
one cigarette may cause a decrease in gingival blood
flow and vascular conductance [10]. Small repeated
vasoconstrictive attacks and impairment of revasculari-
zation due to cigarette smoking may contribute to dis-
ruption of the immune response and delay in the
healing response, leading to an increased risk of period-
ontal disease. Gingival blood flow in periodontally
healthy regular smokers significantly increased three
days after quitting, and further small increases occurred
until eight weeks compared to the baseline [11].
Vascular dysfunction may be related to impairment of
oxygen delivery to gingival tissue. Smokers exhibited
lower function of oxygen sufficiency in healthy gingiva
and reduced ability to adapt to the function in inflamed
gingiva, compared to non-smokers [12]. Pocket oxygen
tension was significantly lower in smokers than in non-
smokers, possibly due to impaired microcirculatory
function. Correlation of pocket oxygen tension to gingi-
val oxygen saturation of hemoglobin was highly signifi-
cant in non-smokers, but this association was absent in
smokers [13].
Smoking-induced endothelial dysfunction may lead to
inflammatory activation within the vascular wall,
mediated by cytokines and adhesion molecules. Intercel-
lular adhesion molecule-1 (ICAM-1) is expressed on the
cell surface of the endothelium of the gingival vascula-
ture and in the junctional epithelium; it is critical in leu-
kocyte trafficking through gingival tissue. The level of
soluble ICAM-1 (sICAM-1) was higher in smokers than
in age-matched non-smoking controls [14]. The mean
serum sICAM-1 concentration was elevated in smokers
compared to non-smokers. Conversely, the mean con-
centration of sICAM-1 in GCF of subjects with period-
ontitis was significantly lower in smokers than in non-
smokers [15].
Host Immune System
The number of neutrophils in GCF was lower or
remained constant in smokers compared to non-
Table 1 Biomarkers employed in studies on smoking and periodontal disease
Target of qualification Biomarkers Specimens
Host responses
Microcirculatory system Microcirculatory functions and intercellular adhesion molecule Gingival microvasculature
Host immune inflammatory
response systems
Immune cells and immunoglobulins Blood serum, saliva, gingival crevicular fluid,
and gingival tissue
Connective tissue and bone
metabolism
Cytokines, prostanoids, and matrix metalloproteinase
Genetic factors Genotypes associated with the immune system, inflammation,
and tissue metabolism
Blood, buccal swabs, and saliva
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increase in blood in a dose-dependent manner [17].
Deleterious effects of smoking on the function of poly-
morphonuclear neutrophils, including reduced viability
and phagocytosis, were observed in periodontally healthy
smokers, in a dose-response manner [18]. Although
there are some conflicting data, smoking may alter neu-
trophil behavior in periodontal tissue. It is reported that
lung macrophages are functionally compromised, e.g.,
reduction in capacity to produce cytokines and phagocy-
tize microorganisms [19].
Limited evidence suggests that smoking may influence
lymphocyte numbers and antibody production. In a pre-
vious study, smoking was significantly associated with
an increased number of CD3+ and CD4+ T cells with a
clear dose-response effect, whereas CD19+ B cells were
not affected by smoking [20]. The CD4+ and CD8+ T
cell values after periodontal treatment were lower in
smokers than in non-smokers [21]. The serum level of
IgG (Immunoglobulin G), particularly IgG2, which is an
important antibody against gram-negative periodontal
pathogens, was decreased in periodontitis patients who
were smokers [22-27]. These findings suggest that
smoking decreases the proliferative capacity of T cells
or T-cell-dependent antibody responses that affect B-
cell function and antibody generation.
Connective Tissue and Bone Metabolism
Among several cytokines, levels of interleukin (IL)-1 in
GCF have been extensively compared between smokers
and non-smokers. Smokers exhibited significantly lower
concentrations of IL-1a and IL-1ra in GCF than non-
smokers [16,28]. The GCF level of IL-1b at deep bleed-
ing sites was lower in smokers than in non-smokers
[29]. This level was not different between smokers and
non-smokers prior to periodontal therapy; however, it
was significantly higher in smokers than in non-smokers
at diseased sites following therapy [25]. Healthy smokers
exhibited higher total amounts of IL-1b in GCF than
non-smokers [30]. Serum IL-1b in patients with
untreated aggressive periodontitis showed a positive cor-
relation with smoking [31].
Other ILs, such as IL-4, IL-6, IL-8, and IL-10, and
tumor necrosis factor-a (TNF-a) have also been investi-
gated. The total amount of IL-4 in GCF was lower in
smokers than in non-smokers and remained stable in
smokers but decreased in non-smokers during induction
of experimental gingivitis [32]. Smokers with early onset
periodontitis exhibited lower levels of IL-4 in GCF than
non-smokers [33]. The total amount of IL-10 in GCF at
diseased sites was significantly lower in smokers than in
non-smokers [25]; however, the levels of IL-6 and IL-8
in GCF were higher in smokers than in non-smokers
[32,33]. Smokers exhibited a significantly higher level of
TNF-a than non-smokers, though smoking was not
associated with levels of IL-1b, IL-1ra, and IL-6 in GCF
[34,35].
Considering these findings, smokers tend to exhibit
excess production of inflammatory molecules, such as
IL-6, IL-8, and TNF-a, and suppression of anti-inflam-
matory molecules, such as IL-4, IL-10, and IL-1ra; how-
ever, these findings are partly inconsistent.
IL-8 can attract and activate neutrophils. Findings
regarding the effects of smoking on the level of neutro-
phil-derived proteolytic enzymes in oral specimens are
inconsistent; however, smoking may increase their level
in systemic circulation. Smokers had significantly higher
elastase concentrations in GCF than non-smokers,
regardless of pocket depths [36,37], while elastase con-
centrations decreased in smokers compared to non-
smokers [38] and former smokers [18]. Plasma matrix
metalloproteinase-9 (MMP-9) of smokers was 6.45 times
higher than that of non-smokers [39]. Smoking was
highly correlated with the MMP-3 level in GCF [40].
MMP-8 expression in periodontal tissue was signifi-
cantly higher in smokers than in non-smokers [41],
while the salivary MMP-8 level was significantly lower
in current smokers than in former smokers [42]. Smok-
ing may suppress the activities of protease inhibitors.
Smokers had a significantly lower concentration of a-2-
macroglobulin in GCF as well as total amounts of a-2-
macroglobulin and a-1-antitrypsin than non-smokers
[43]. Smoking seems to disturb the balance between
proteolytic and anti-proteolytic activities in periodontal
tissue.
IL-1, IL-6, and TNF-a stimulate the expression of the
receptor activator of nuclear factor-b ligand (RANKL)
and the inhibitor protein osteoprotegerin (OPG), which
are essential factors for bone resorption and remodeling.
Smoking did not affect the mean levels of free soluble
RANKL (sRANKL) in GCF [44]. The OPG concentra-
tion was significantly lower and the sRANKL/OPG ratio
was higher in smokers than in non-smokers, in saliva
[45] as well as serum [46], explaining the greater poten-
tial for bone loss in smokers.
IL-1 and IL-6 induce production of prostaglandin E2
(PGE2) by neutrophils and macrophages, which could
also promote periodontal bone resorption. However, the
level of PGE2 in GCF in smokers was similar to that in
non-smokers [47,48] or even lower than that in non-
smokers [49,36]. The level of salivary PGE2 was also
lower in smokers than in non-smokers [50]. Interference
of prostaglandin production may be related to the vaso-
constricting effect of smoking [51] (refer Microcircula-
tory system).
The level of free oxygen radicals in periodontal tissues
was increased in smokers compared to non-smokers
[52]. Oxidative stress induces tissue damage by injuring
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attachment and growth of fibroblasts derived from
human periodontal ligaments [53]. Fibroblasts impaired
by smoking possibly lead to delay in tissue repair and
wound healing in periodontal disease.
Smoking-associated pathophysiological changes in per-
iodontal tissue evaluated by biological measurements are
summarized in Table 2. Reduction in GCF observed in
smokers may influence the conflicting results between
the levels of several biomarkers in GCF and blood. It
remains unclear whether these changes are due to nico-
tine or other components of tobacco smoke and sys-
temic or local effects of smoking. The common
mechanism in periodontal and systemic disease under
the influence of smoking may be revealed by markers
for inflammatory responses, tissue damage, and vascular
effects [54].
Genetic factors
Gene polymorphisms have been investigated as possible
markers of increased susceptibility to periodontal dis-
eases: IL-1, IL-4, IL-10; TNF-a;F c g receptor; human
leukocyte antigen; vitamin D receptor; and N-formyl
peptide receptor [55]. Relationships between smoking
and genetic susceptibility to periodontal diseases have
been strengthened with respect to genotypes associated
with cytokines (IL-1, IL-6, and IL-10), the immune sys-
tem (Fcg receptor), bone metabolism (vitamin D recep-
tor), and xenobiotics metabolism (N-acetyltransferase
and myeloperoxidase). These studies have been listed in
Table 3.
IL-1 polymorphisms have been intensively studied
using a cross-sectional approach, except for one study
that employed a longitudinal design [56]. The relation-
ship with respect to smoking is controversial. The
association between positive genotypes and the severity
of periodontal disease was independent of smoking
[ 5 7 , 5 8 ] ,s u g g e s t i n gn or e l a t i o n s h i pb e t w e e ns m o k i n g
and IL-1 genotypes; however, relationships between
IL-1-positive genotypes and smoking was evident
[59-63]. Logistic regression analysis of periodontal dis-
ease with genotype-negative non-smokers as a refer-
ence group exhibited odds ratios of 0.98 for genotype-
positive non-smokers, 2.37 for genotype-negative
smokers, and 4.50 for genotype-positive smokers, thus
suggesting synergism between IL-1 polymorphism and
smoking [64].
Non-smokers with moderate periodontitis and period-
ontally healthy subjects displayed a higher incidence of
IL-6 G-genotype than severe periodontitis subjects [65].
The difference in the occurrence of the IL-10 GG geno-
type between severe chronic periodontitis and control
groups was more evident in non-smokers [66]. Gene
coding for the ligand-binding chain of interferon
gamma receptor 1, a cytokine that plays a pivotal role
in defense against infection, was significantly associated
with periodontitis in combination with smoking [67].
IgG-binding factors, namely Fcg receptors, could influ-
ence the ability of phagocytosis. Genotypes of Fcg
receptor, FcgRIIa, and FcgRIIIb, may be associated with
periodontal disease in smokers [68,69]. Vitamin D
receptor Taq-I TT polymorphism was moderately
Table 2 Pathophysiological changes associated with smoking
Target of qualification Biomarkers* Articles
Microcirculatory system Gingival blood flow (chronic effect ↓ and acute effect ↑, quit effect ↑)
Number of vessels in inflamed site↓ (Gingival bleeding ↓)
Oxygen sufficiency ↓
Pocket oxygen tension ↓
sICAM-1 ? (Serum ↑ and GCF ↓)
9-11
8
12
13
14, 15
Host immune inflammatory response systems PMNs or neutrophil count ? (blood↑ and GCF↓)
PMN function (chemotaxis, phagocytosis, and oxidative burst) ↓
Macrophage function ↓
T lymphocytes ?
IgG2 ↓
16, 17
18
19**
17, 20, 21
22-27
Connective tissue and bone metabolism IL-1a/b and IL-1ra ↓
IL-6 and IL-8 ↑, IL-4, and IL-10 ↓,TNF-a ↑
Elastase activity ?
MMP-9 and MMP-3 in GCF ↑
MMP-8 ? (GCF ↑ and saliva ↓)
a-2-Macroglobulin
↓ OPG ↓ and sRANKL/OPG ratio ↑
Prostaglandin E2 ↓
Free radicals ↑
Gingival fibroblast ↓ (Tissue repair and wound healing ↓)
16, 25, 28-31
25, 32-35
18, 36-38
39, 40
41, 42
43
44-46
36, 47-50
52
53
*↑: increase, ↓: decrease, ?: uncertain. **Lung macrophages
ICAM-1: intercellular adhesion molecule-1, GCF: gingival crevicular fluid, PMN: polymorphonuclear neutrophil, IgG: immunoglobulin G, IL: interleukin, TNF-a: tumor
necrosis factor-a, MMP: matrix metalloproteinase, OPG: osteoprotegerin, RANKL: receptor activator of nuclear factor-b ligand
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periodontitis in smokers [70]. Gene polymorphisms for
enzymes that can metabolize smoking-derived sub-
stances may contribute to individual susceptibility to
the risk of periodontitis among smokers. Subjects with
the polymorphic cytochrome P450 1A1 M2 allele and
glutathione S-transferase M1 allele exhibited an
increased risk of periodontitis [71].
Conclusions
The process of periodontal disease is such that a micro-
bial challenge induces a host response, which may result
in connective tissue and alveolar bone destruction. Most
findings support that smoking modulates the destruction
of the periodontium through different pathways: micro-
circulatory and host immune systems, connective tissue,
and bone metabolism. Although smokers exhibit an
Table 3 Target genotypes and study population in association with periodontal disease and smoking
Genotypes Subjects Main findings Articles
IL-1A -889, IL-1B
+3954 (originally
described as +3953)
134 subjects, USA The polymorphic IL-1 gene cluster was associated with
severity of periodontitis only in non-smokers.
59
IL-1A -889, IL-1B
+3954 (originally
described as +3953)
28 African-American and 7 Caucasian-American
families (early onset periodontitis affected and
unaffected subjects), USA
IL-1ß disequilibrium with EOP was found both in smokers and
non-smokers.
57
IL-1A -889 46 patients and 12 controls, UK The carriage of allele 2 was associated with an increase in IL-l
a protein levels, especially in non-smokers, while heavy
smokers showed reduced levels of IL-la protein, regardless of
genotype.
28
IL-1A -4845, IL-1B
-3954
295 Caucasians, Australia A relationship was observed between the IL-1-positive
genotype and increased mean probing pocket depth in non-
smokers more than 50 years of age. IL-1 genotype-positive
smokers had an increase in the number of probing depths
≥3.5 mm.
56
IL-1A +4845, IL-B
+3954
90 patients (non- or former smokers), USA IL-1 genotype-positive non-smokers or former light smokers
were at increased odds of having moderate-to-severe
periodontal disease compared to IL-1 genotype-negative
patients. The presence of both former moderate smoking
history and IL-1-positive genotype showed a lower likelihood
of developing the disease when compared to those with
presence of only one of the risk factors.
60
IL-1A -889, IL-1B
+3954, IL-1RN
154 Caucasians, Germany Severity of periodontitis was associated with the composite
genotype of IL-1a/1b in smokers, while no differences were
found in genotype-negative subjects, irrespective of their
smoking status.
62
IL-1A -889, IL-1B
+3954, IL-1B -511
1085 Caucasians, Germany An increased risk of periodontal disease and tooth loss was
observed for IL-1 genotype-positive smokers.
61, 63,
64
IL-1A -889 IL-1B +3954 330 patients and 101 controls, Chile The association between positive genotype and periodontitis
was independent of smoking status.
58
IL-6 -174 155 patients and 54 controls, Brazil An association between the G-genotype and periodontal
status was observed only in non-smokers.
65
IL-10 -1087 60 patients and 39 controls, Sweden An association between the GG genotype and periodontal
status was more conspicuous in non-smokers.
66
Vitamin D receptor
-1056 Taq-I
303 patients and 231 controls, UK Vitamin D receptor Taq-I TT polymorphism was moderately
associated with both the presence and progression of
periodontitis in smokers.
70
FcgRIIIb 164 subjects aged 70 years old, Japan An association between smoking and periodontal disease
progression in elderly people with FcgRIIIb-NA2
polymorphism.
68
FcgRIIa 422 Caucasians, USA FcgRIIa-H/H131 genotype may be associated with chronic
periodontitis risk in smokers.
69
FcgRIIIa -158V/F,
FcgRIIIb -NA1/NA2
1083 Caucasians, Germany Smokers show a significantly increased attachment loss in the
presence of FcgRIIIb-NA2 allele. The different genotypes show
no differences in non-smokers.
63
IFNGR1 62 patients and 56 controls, Norway In combination with smoking, IFNGR1 was significantly
associated with periodontitis.
67
NAT2 -T341C, -G590A,
G857A MPO G-463ª
1083 Caucasians, Germany Smokers with the high activity variant of NAT 2 and MPO are
at an increased risk of periodontitis.
63
IL: interleukin, FcgR: Fcg receptor, IFNGR1: interferon gamma receptor 1, NAT: N-acetyltransferase, MPO: myeloperoxidase
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bial challenges compared to non-smokers, substantial
problems still persists with respect to the accuracy of
measurements, and particularly, the sampling of many
subjects. Limited evidences are available regarding the
effects of quitting smoking on pathophysiological
changes in periodontal tissue.
At present, gene-smoking relationships in periodontal
disease are suggestive. The reported gene-smoking rela-
tionships in periodontal disease should be carefully
interpreted in two ways. First is the uncertainty of the
relationship because of methodological limitations such
as employment of subjects in a specific race, small sam-
ple size, and lack of detailed history of smoking and
possible confounders. Further studies with adequate sta-
tistical power and small biases would be required to
clarify the relationship. Furthermore, it remains unclear
whether genetic susceptibility to periodontal disease is
influenced by exposure to smoking or the effect of
smoking on periodontal disease is influenced by genetic
susceptibility. The second issue is an ethical problem. If
a smoker with positive genotypes associated with inflam-
matory cytokines is proven to be at a high risk of peri-
odontal disease, the evidence is so strong that the
smoker should be encouraged to quit smoking. In con-
trast, however, the evidence may cause a smoker with
negative genotypes to avoid quitting smoking, thereby
causing fatal diseases. Within such limitations, gene-
environment relationship studies possibly provide valu-
able insights into the pathogenesis of complex periodon-
tal diseases and are expected to contribute to prevent
t h ed i s e a s et h r o u g hp e r s o n a lized recommendation and
targeted intervention in dental public and clinical
programs.
Employment of molecular techniques may play a key
role in further elucidation of mechanisms linking smok-
ing and periodontal destruction, the direct relationship
as environmental factors and indirect relationship
through genetic factors.
Acknowledgements
TH is supported by a Grant-in-Aid for Cancer Research (17-1), Health and
Labor Sciences Research Grants for Clinical Cancer Research (H19-010),
Comprehensive Research on Cardiovascular and Life-Style Related Diseases
(H19-007) from the Ministry of Health, Labor, and Welfare, Japan, and Grant-
in-Aid for Exploratory Research from the Japan Society for the Promotion of
Science.
Author details
1Department of Preventive Dentistry, Graduate School of Dentistry, Osaka
University, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan.
2Department of
Preventive and Public Health Dentistry, Fukuoka Dental College, 2-15-1
Tamura, Sawara-ku, Fukuoka 814-0193, Japan.
Authors’ contributions
MO evaluated the literature and drafted the manuscript. TH conceived the
idea for the review and helped draft the manuscript. Both authors
participated in the design and coordination of the review. They also read
and approved the final version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 17 October 2009
Accepted: 20 February 2010 Published: 20 February 2010
References
1. Nunn ME: Understanding the etiology of periodontitis: an overview of
periodontal risk factors. Periodontol 2000 2003, 32:11-23.
2. Mullally BH: The influence of tobacco smoking on the onset of
periodontitis in young persons. Tob Induc Dis 2004, 2:53-65.
3. US Department of Health and Human Services: Dental diseases. The Health
Consequences of Smoking. A Report of the Surgeon General Washington DC:
US Department of Health and Human ServicesSamet JM, Norman LA,
Wilbanks C 2004, 732-766.
4. Hill AB: The environment and disease: association or causation?. Proc R
Soc Med 1965, 58:295-300.
5. Schulte PA: Molecular Epidemiology: Principles and Practices. San Diego
Academic Press 1993.
6. Shield PG: Molecular epidemiology of smoking and lung cancer.
Oncogene 2002, 21:6870-6876.
7. Palmer RM, Wilson RF, Hasan AS, Scott DA: Mechanisms of action of
environmental factors-tobacco smoking. J Clin Periodontol 2005,
32:180-195.
8. Rezavandi K, Palmer RM, Odell EW, Scott DA, Wilson RF: Expression of
ICAM-1 and E-selectin in gingival tissues of smokers and non-smokers
with periodontitis. J Oral Pathol Med 2002, 31:59-64.
9. Mavropoulos A, Aars H, Brodin P: Hyperaemic response to cigarette
smoking in healthy gingiva. J Clin Periodontol 2003, 30:214-221.
10. Mavropoulos A, Brodin P, Rosing CK, Aass AM, Aars H: Gingival blood flow
in periodontitis patients before and after periodontal surgery assessed
in smokers and non-smokers. J Periodontol 2007, 78:1774-1782.
11. Morozumi T, Kubota T, Sato T, Okuda K, Yoshie H: Smoking cessation
increases gingival blood flow and gingival crevicular fluid. J Clin
Periodontol 2004, 31:267-272.
12. Hanioka T, Tanaka M, Ojima M, Takaya K, Matsumori Y, Shizukuishi S:
Oxygen sufficiency in the gingiva of smokers and non-smokers with
periodontal disease. J Periodontol 2000, 71:1846-1851.
13. Hanioka T, Tanaka M, Takaya K, Matsumori Y, Shizukuishi S: Pocket oxygen
tension in smokers and non-smokers with periodontal disease. J
Periodontol 2000, 71:550-554.
14. Koundouros E, Odell E, Coward P, Wilson R, Palmer RM: Soluble adhesion
molecules in serum of smokers and non-smokers, with and without
periodontitis. J Periodontal Res 1996, 31:596-599.
15. Fraser HS, Palmer RM, Wilson RF, Coward PY, Scott DA: Elevated systemic
concentrations of soluble ICAM-1 (sICAM) are not reflected in the
gingival crevicular fluid of smokers with periodontitis. J Dent Res 2001,
80:1643-1647.
16. Petropoulos G, McKay IJ, Hughes FJ: The association between neutrophil
numbers and interleukin-1alpha concentrations in gingival crevicular
fluid of smokers and non-smokers with periodontal disease. J Clin
Periodontol 2004, 31:390-395.
17. Loos BG, Roos MTL, Schellekens PTA, Velden van der U, Miedema F:
Lymphocyte numbers and function in relation to periodontitis and
smoking. J Periodontol 2004, 75:557-564.
18. Guntsch A, Erler M, Preshaw PM, Sigusch BW, Klinger G, Glockmann E:
Effect of smoking on crevicular polymorphonuclear neutrophil function
in periodontally healthy subjects. J Periodontal Res 2006, 41:184-188.
19. Barbour SE, Nakashima K, Zhang JB, Tangada S, Hahn CL, Schenkein HA,
Tew JG: Tobacco and smoking: environmental factors that modify the
host response (immune system) and have an impact on periodontal
health. Crit Rev Oral Biol Med 1997, 8:437-60.
20. Pauletto NC, Liede K, Nieminen A, Larjava H, Uitto VJ: Effect of cigarette
smoking on oral elastase activity in adult periodontitis patients. J
Periodontol 2000, 71:58-62.
21. Orbak R, Erciyas K, Kaya H: Flow-cytometric analysis of T-lymphocyte
subsets after different treatment methods in smokers and non-smokers
with chronic periodontitis. Int Dent J 2003, 53:159-164.
Ojima and Hanioka Tobacco Induced Diseases 2010, 8:4
http://www.tobaccoinduceddiseases.com/content/8/1/4
Page 6 of 822. Quinn SM, Zhang JB, Gunsolley JC, Schenkein HA, Tew JG: The influence of
smoking and race on adult periodontitis and serum IgG2 levels. J
Periodontol 1998, 69:171-177.
23. Califano JV, Schifferle RE, Gunsolley JC, Best AM, Schenkein HA, Tew JG:
Antibody reactive with Porphyromonas gingivalis serotypes K1-6 in
adult and generalized early-onset periodontitis. J Periodontol 1999,
70:730-735.
24. Graswinckel JE, Velden van der U, van Winkelhoff AJ, Hoek FJ, Loos BG:
Plasma antibody levels in periodontitis patients and controls. J Clin
Periodontol 2004, 31:562-568.
25. Goutoudi P, Diza E, Arvanitidou M: Effect of periodontal therapy on
crevicular fluid interleukin-1beta and interleukin-10 levels in chronic
periodontitis. J Dent 2004, 32:511-520.
26. Al-Ghamdi HS, Anil S: Serum antibody levels in smoker and non-smoker
saudi subjects with chronic periodontitis. J Periodontol 2007,
78:1043-1050.
27. Gunsolley JC, Pandey JP, Quinn SM, Tew J, Schenkein HA: The effect of
race, smoking and immunoglobulin allotypes on IgG subclass
concentrations. J Periodontal Res 1997, 32:381-387.
28. Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ: Polymorphisms in
the IL-1A gene are correlated with levels of interleukin-1alpha protein in
gingival crevicular fluid of teeth with severe periodontal disease. J Dent
Res 2000, 79:1864-1869.
29. Rawlinson A, Grummitt JM, Walsh TF, Ian Douglas CW: Interleukin 1 and
receptor antagonist levels in gingival crevicular fluid in heavy smokers
versus non-smokers. J Clin Periodontol 2003, 30:42-48.
30. Kamma JJ, Giannopoulou C, Vasdekis VGS, Mombelli A: Cytokine profile in
gingival crevicular fluid of aggressive periodontitis: influence of smoking
and stress. J Clin Periodontol 2004, 31:894-902.
31. Mengel R, Bacher M, Flores-De-Jacoby L: Interactions between stress,
interleukin-1beta, interleukin-6 and cortisol in periodontally diseased
patients. J Clin Periodontol 2002, 29:1012-1022.
32. Giannopoulou C, Cappuyns I, Mombelli A: Effect of smoking on gingival
crevicular fluid cytokine profile during experimental gingivitis. J Clin
Periodontol 2003, 30:996-1002.
33. Giannopoulou C, Kamma JJ, Mombelli A: Effect of inflammation, smoking
and stress on gingival crevicular fluid cytokine level. J Clin Periodontol
2003, 30:145-153.
34. Boström L, Linder LE, Bergström J: Clinical expression of TNF-alpha in
smoking-associated periodontal disease. J Clin Periodontol 1998,
25:767-773.
35. Boström L, Linder LE, Bergström J: Smoking and crevicular fluid levels of
IL-6 and TNF-alpha in periodontal disease. J Clin Periodontol 1999,
26:352-357.
36. Söder B, Jin LJ, Wickholm S: Granulocyte elastase, matrix
metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in
matched clinical sites in smokers and non-smokers with persistent
periodontitis. J Clin Periodontol 2002, 29:384-391.
37. Söder B: Neutrophil elastase activity, levels of prostaglandin E2, and
matrix metalloproteinase-8 in refractory periodontitis sites in smokers
and non-smokers. Acta Odontol Scand 1999, 57:77-82.
38. Alavi AL, Palmer RM, Odell EW, Coward PY, Wilson RF: Elastase in gingival
crevicular fluid from smokers and non-smokers with chronic
inflammatory periodontal disease. Oral Dis 1995, 1:110-114.
39. Söder B, Airila MS, Söder PO, Kari K, Meurman J: Levels of matrix
metalloproteinases-8 and -9 with simultaneous presence of periodontal
pathogens in gingival crevicular fluid as well as matrix
metalloproteinase-9 and cholesterol in blood. J Periodontal Res 2006,
41:411-417.
40. Alpagot T, Bell C, Lundergan W, Chambers DW, Rudin R: Longitudinal
evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for
progression of periodontitis. J Clin Periodontol 2001, 28:353-359.
41. Liu KZ, Hynes A, Man A, Alsagheer A, Singer DL, Scott DA: Increased local
matrix metalloproteinase-8 expression in the periodontal connective
tissues of smokers with periodontal disease. Biochim Biophys Acta 2006,
1762:775-780.
42. Liede KE, Haukka JK, Hietanen JH, Mattila MH, Ronka H, Sorsa T: The
association between smoking cessation and periodontal status and
salivary proteinase levels. J Periodontol 1999, 70:1361-1368.
43. Persson L, Bergström J, Ito H, Gustafsson A: Tobacco smoking and
neutrophil activity in patients with periodontal disease. J Periodontol
2001, 72:90-95.
44. Sakellari D, Menti S, Konstantinidis A: Free soluble receptor activator of
nuclear factor-kappab ligand in gingival crevicular fluid correlates with
distinct pathogens in periodontitis patients. J Clin Periodontol 2008,
35:938-943.
45. Buduneli N, Biyikoglu B, Sherrabeh S, Lappin DF: Saliva concentrations of
RANKL and osteoprotegerin in smoker versus non-smoker chronic
periodontitis patients. J Clin Periodontol 2008, 35:846-852.
46. Lappin DF, Sherrabeh S, Jenkins WMM, Macpherson LMD: Effect of
smoking on serum RANKL and OPG in sex, age and clinically matched
supportive-therapy periodontitis patients. J Clin Periodontol 2007,
34:271-277.
47. Preshaw PM, Lauffart B, Zak E, Jeffcoat MK, Barton I, Heasman PA:
Progression and treatment of chronic adult periodontitis. J Periodontol
1999, 70:1209-1220.
48. Heasman PA, Lauffart BL, Preshaw PM: Crevicular fluid prostaglandin E2
levels in periodontitis-resistant and periodontitis-susceptible adults. J
Clin Periodontol 1998, 25:1003-1007.
49. Zhong Y, Slade GD, Beck JD, Offenbacher S: Gingival crevicular fluid
interleukin-1beta, prostaglandin E2 and periodontal status in a
community population. J Clin Periodontol 2007, 34:285-293.
50. Kibayashi M, Tanaka M, Nishida N, Kuboniwa M, Kataoka K, Nagata H,
Nakayama K, Morimoto K, Shizukuishi S: Longitudinal study of the
association between smoking as a periodontitis risk and salivary
biomarkers related to periodontitis. J Periodontol 2007, 78:859-867.
51. Goodfield MJD, Hume A, Rowell NR: The acute effects of cigarette
smoking on cutaneous blood flow in smoking and nonsmoking subjects
with and without Raynaud’s phenomenon. Br J Rheumatol 1990, 29:89-91.
52. Garg N, Singh R, Dixit J, Jain A, Tewari V: Levels of lipid peroxides and
antioxidants in smokers and nonsmokers. J Periodontal Res 2006,
41:405-410.
53. James JA, Sayers NM, Drucker DB, Hull PS: Effects of tobacco products on
the attachment and growth of periodontal ligament fibroblasts. J
Periodontol 1999, 70:518-25.
54. Berlin I: Smoking-induced metabolic disorders: a review. Diabetes Metab
2008, 34:307-314.
55. Meng H, Xu L, Li Q, Han J, Zhao Y: Determinants of host susceptibility in
aggressive periodontitis. Periodontol 2000 2007, 43:133-159.
56. Cullinan MP, Westerman B, Hamlet SM, Palmer JE, Faddy MJ, Lang NP,
Seymour GJ: A longitudinal study of interleukin-1 gene polymorphisms
and periodontal disease in a general adult population. J Clin Periodontol
2001, 28:1137-1144.
57. Diehl SR, Wang Y, Brooks CN, Burmeister JA, Califano JV, Wang S,
Schenkein HA: Linkage disequilibrium of interleukin-1 genetic
polymorphisms with early-onset periodontitis. J Periodontol 1999,
70:418-430.
58. Lopéz NJ, Jara L, Valenzuela CY: Association of interleukin-1
polymorphisms with periodontal disease. J Periodontol 2005, 76:234-243.
59. Kornman KS, Crane A, Wang HY, di Giovine FS, Newman MG, Pirk FW,
Wilson TG Jr, Higginbottom FL, Duff GW: The interleukin-1 genotype as a
severity factor in adult periodontal disease. J Clin Periodontol 1997,
24:72-77.
60. McDevitt MJ, Wang HY, Knobelman C, Newman MG, di Giovine FS,
Timms J, Duff GW, Kornman KS: Interleukin-1 genetic association with
periodontitis in clinical practice. J Periodontol 2000, 71:156-163.
61. Meisel P, Siegemund A, Grimm R, Herrmann FH, John U, Schwahn C,
Kocher T: The interleukin-1 polymorphism, smoking, and the risk of
periodontal disease in the population-based SHIP study. J Dent Res 2003,
82:189-193.
62. Meisel P, Siegemund A, Dombrowa S, Sawaf H, Fanghaenel J, Kocher T:
Smoking and polymorphisms of the interleukin-1 gene cluster (IL-
1alpha, IL-1beta, and IL-1RN) in patients with periodontal disease. J
Periodontol 2002, 73:27-32.
63. Meisel P, Heins G, Carlsson L, Giebel J, John U, Schwahn C, Kocher T:
Impact of genetic polymorphisms on the smoking-related risk of
periodontal disease: the population-based study SHIP. Tob Induc Dis
2003, 1:197.
Ojima and Hanioka Tobacco Induced Diseases 2010, 8:4
http://www.tobaccoinduceddiseases.com/content/8/1/4
Page 7 of 864. Meisel P, Schwahn C, Gesch D, Bernhardt O, John U, Kocher T: Dose-effect
relation of smoking and the interleukin-1 gene polymorphism in
periodontal disease. J Periodontol 2004, 75:236-242.
65. Moreira PR, Lima PM, Sathler KO, Imanishi SA, Costa JE, Gomes RS,
Gollob KJ, Dutra WO: Interleukin-6 expression and gene polymorphism
are associated with severity of periodontal disease in a sample of
Brazilian individuals. Clin Exp Immunol 2007, 148:119-126.
66. Berglundh T, Donati M, Hahn-Zoric M, Hanson LA, Padyukov L: Association
of the -1087 IL 10 gene polymorphism with severe chronic periodontitis
in Swedish Caucasians. J Clin Periodontol 2003, 249-254.
67. Fraser DA, Loos BG, Boman U, van Winkelhoff AJ, Velden van der U,
Schenck K, Dembic Z: Polymorphisms in an interferon-gamma receptor-1
gene marker and susceptibility to periodontitis. Acta Odontol Scand 2003,
61:297-302.
68. Yoshihara A, Sugita N, Yamamoto K, Kobayashi T, Hirotomi T, Ogawa H,
Miyazaki H, Yoshie H: FcgammaRIIIb genotypes and smoking in
periodontal disease progression among community-dwelling older
adults in Japan. J Periodontol 2005, 76:250-255.
69. Yamamoto K, Kobayashi T, Grossi S, Ho AW, Genco RJ, Yoshie H, De
Nardin E: Association of Fcgamma receptor IIa genotype with chronic
periodontitis in Caucasians. J Periodontol 2004, 75:517-522.
70. Nibali L, Parkar M, D’Aiuto F, Suvan JE, Brett PM, Griffiths GS, Rosin M,
Schwahn C, Tonetti MS: Vitamin D receptor polymorphism (-1056 Taq-I)
interacts with smoking for the presence and progression of
periodontitis. J Clin Periodontol 2008, 35:561-567.
71. Kim JS, Park JY, Chung WY, Choi MA, Cho KS, Park KK: Polymorphisms in
genes coding for enzymes metabolizing smoking-derived substances
and the risk of periodontitis. J Clin Periodontol 2004, 31:959-964.
doi:10.1186/1617-9625-8-4
Cite this article as: Ojima and Hanioka: Destructive effects of smoking
on molecular and genetic factors of periodontal disease. Tobacco
Induced Diseases 2010 8:4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ojima and Hanioka Tobacco Induced Diseases 2010, 8:4
http://www.tobaccoinduceddiseases.com/content/8/1/4
Page 8 of 8